South Korea Sequencing Market Size, Share, and COVID-19 Impact Analysis, By Product & Services (Consumables, Platform, and Software), By Application (Oncology and Clinical Investigation), By Workflow (Sequencing and Data Analysis), and South Korea Sequencing Market Insights, Industry Trend, Forecasts to 2035

South Korea Sequencing Market Insights Forecasts to 2035

• The South Korea Sequencing Market Size Was Estimated at USD 459.1 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 19.58% from 2025 to 2035
• The South Korea Sequencing Market Size is Expected to Reach USD 3,989.6 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The South Korea Sequencing Market Size is anticipated to Reach USD 3,989.6 Million by 2035, Growing at a CAGR of 19.58% from 2025 to 2035. Growing need for customized medicine, gene therapy, drug development, rising cancer rates, and a notable surge in consumer genomics demand in recent years are some of the causes driving the market's expansion.

Market Overview

The market for technology and services that pinpoint the exact arrangement of nucleotides (A, T, C, and G) in a DNA or RNA molecule is known as the sequencing market. This covers the creation, production, and marketing of tools, chemicals, and software in addition to provide sequencing services. Developments in next-generation sequencing (NGS) technology, which make high-throughput, quicker, and less expensive DNA analysis possible, are driving the market. Applications are found in many different domains, including agriculture, diagnostics, personalized medicine, and genomics research. Sequencing data offers important information on possible therapeutic targets and disease causes. This information speeds up the drug discovery process, resulting in the creation of more specialized and potent treatments. The diagnosis and comprehension of uncommon genetic illnesses, sequencing opens the door to possible treatments and prophylactic actions. Sequencing informs treatment choices and public health initiatives by tracking and comprehending the spread of microorganisms resistant to antibiotics. Numerous regional and national programs are being started to encourage genomic research, such as those aimed at figuring out the genetic causes of illnesses and creating individualized treatment strategies.

Report Coverage

This research report categorizes the market for South Korea sequencing market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea sequencing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea sequencing market.

Driving Factors

Rapid advancement in next-generation sequencing (NGS) technologies, which offer faster, more accurate, and cost-effective genomic analysis. Growing applications in personalized medicine, oncology, and genetic disease research fuel demand. Increasing government funding and private investments in genomics research accelerate market growth. Additionally, the rising prevalence of chronic diseases and the need for early diagnosis boost sequencing adoption. Expanding use in clinical trials and pharmaceutical development further propels the market, alongside improvements in bioinformatics and data analysis tools.

Restraining Factors

Data management challenges due to large volumes of complex genomic data require significant computational resources and expertise. Privacy concerns and stringent regulations around genetic data sharing slow adoption. Additionally, a lack of standardized protocols and limited skilled professionals in bioinformatics hinders efficient utilization.

Market Segmentation

The South Korea sequencing market share is classified into product & service, application, and workflow.

• The consumables segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea sequencing market is segmented by product & service into consumables, platform, and software. Among these, the consumables segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. Growth is driven by rising sequencing volumes in clinical and research settings, increasing adoption of next-generation sequencing (NGS), and demand for high-quality reagents, kits, and sample preparation materials.

• The oncology segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea sequencing market is segmented by application into oncology and clinical investigation. Among these, the oncology segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The rising cancer prevalence and increasing demand for precision medicine. Growth is driven by advancements in genomic profiling, early cancer detection, and targeted therapies, driving widespread adoption of sequencing technologies for personalized oncology diagnostics and treatment planning.

• The sequencing segment dominated the share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea sequencing market is segmented by workflow into sequencing and data analysis. Among these, the sequencing segment dominated the share in 2024 and is expected to grow at a significant CAGR during the forecast period. The high-throughput, accurate sequencing technologies in research and clinical diagnostics. Its growth is supported by continuous technological advancements, expanding applications in genomics, and rising investments in sequencing infrastructure across the healthcare and biotech sectors.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea sequencing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Seegene Inc.
• Macrogen Inc.
• Samsung Biologics Co., Ltd.
• GeneMatrix Inc.
• Lotte Biologics
• Bioneer Corporation
• Analytik Jena
• Celemics Inc.
• Waters Corporation
• Celltrion, Inc.
• GENOFOCUS
• GENECAST
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea sequencing market based on the below-mentioned segments:

 South Korea Sequencing Market, By Product & Service

• Consumables
• Platform
• Software

South Korea Sequencing Market, By Application

• Oncology
• Clinical Investigation

South Korea Sequencing Market, By Workflow

• Sequencing
• Data Analysis